Pharmaceutical Representative Training

MARCH 17, 2025

Healthcare professionals are also catching up to the patient group, which has long been engaged on social media. It can be applied to comprehend patient difficulties and spot chances for clinical intervention. Patient and healthcare professionals anticipate personalized, communication based on value.

Media 52

Media Sales Pharma Healthcare 52

Impetus Digital

AUGUST 2, 2024

From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. Beyond pharmacogenomics, AI’s role in personalized medicine expands to precision dosing and disease prediction/prevention, including AI-powered risk assessment and lifestyle recommendations.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

Pharmaceutical Technology

MARCH 17, 2023

As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and on the market. Companies are testing the use of digital platforms along with pharmacological treatments. The potential cost of these approaches is also an obstacle.

Prescription 111

Prescription Pharmacology Medical Pharma 111

European Pharmaceutical Review

JULY 27, 2023

Pharmacological therapies mainly address symptoms and unfortunately a significant number of patients do not respond adequately, progressing to congestive heart failure and eventually needing a heart transplant. As this is an autologous therapy, there is a lot of patient-to-patient variability. 1 Furthermore, there are 63.3

Pharmacology 98

Pharmacology Manufacturing Leads Patients 98

Infuse Medical

DECEMBER 17, 2024

Companies in 3D medical animation such as Infuse Med are adept in converting complicated medical jargon into understandable images appealing to patients, doctors, and other stakeholders. Check out some case studies where 3D medical animation simplified communication between healthcare professionals and their patients.

Medical 130

Medical Healthcare Healthcare Education 130

Pharmaceutical Technology

FEBRUARY 8, 2023

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

European Pharmaceutical Review

MARCH 11, 2024

HIV treatment and prevention are at an inflection point after years of continuously improving the standard of care of once-daily oral medicines. Our industry is on the cusp of the next wave of medicines that will guide the coming decade of HIV care, making HIV a smaller part of people’s lives. 3 But that paradigm is rapidly changing.

Medicine 98

Medicine Pharmacology Healthcare Healthcare 98

pharmaphorum

JANUARY 16, 2023

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. And all are predominantly prevented or treated with medicines that are decades old.

FDA 98

FDA Healthcare Healthcare Medicine 98

European Pharmaceutical Review

OCTOBER 19, 2022

Evergreening of patents is the process of patenting post-approval or secondary changes to approved medicinal products. 10 There is a fear that such practices discourage innovative approaches, impacting on patient welfare. Biopharmaceutical Research & Development: The Process Behind New Medicines. The Cato Institute.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

Pharmaceutical Representative Training

JANUARY 30, 2025

Imagine a patient who takes ibuprofen to treat a headache. A drugs solubility, how the liver metabolizes it, and patient-specific factors like genetics can influence the journey of a drug. These details are the reasons why knowledge of PK and PD is fundamental to making every drug both effective and safe for every patient.

Pharmacology 52

Pharmacology Side effects Distribution Sales 52

Pharma Leaders

APRIL 17, 2023

Abliva is a clinical-stage company developing medicines to treat rare and severe primary mitochondrial diseases. The ODD will be beneficial to us as we work to progress NV354 and evaluate the compound in patients who are in urgent need of therapies to relieve their suffering.”

FDA 52

FDA Pharmacology Medicine Leads 52

PM360

NOVEMBER 29, 2022

Food and Drug Administration (FDA) or European Medicines Agency (EMA). Understanding patient sub-group exceptions for competitive or for label development purposes. Typically, a drug label refers to any information provided with prescription drugs, as requested by regulators such as the U.S. Challenges in Working with Label Data.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

Pharmaceutical Technology

APRIL 25, 2023

4DMT will be responsible for licence payments to the University of Pennsylvania, where the Perelman School of Medicine’s pharmacology professor, Dr Wenchao Song, jointly invented and developed the sCFH technology. The firm will also receive single-digit royalties on net sales.

Pharmacology 52

Pharmacology Engineering Sales Medicine 52

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

PM360

MARCH 19, 2024

While everyone was talking about the transformative power of data and AI, the healthcare track repeatedly brought the conversation back to what matters most: patients. Patients were the lens through which all innovation was filtered, and rightly so. Patients must remain the impetus and North Star for the industry’s use of technology.

Healthcare 52

Healthcare Healthcare Pharmacology Medicine 52

Contrarian Sales Techniques

FEBRUARY 25, 2023

During my pharmacology class, I learned that there are no safe drugs, only safe patients. This highlights the importance of taking an individualized approach to medicine and considering a patient's unique medical history, current health status, and other relevant factors when prescribing medication.

Side effects 52

Side effects Medical sales reps Insurance Medical sales 52

MedReps

JUNE 20, 2022

They’ll also teach you about insurance coverage which is vital to selling any medicine. Pharmaceutical reps use the results of clinical trials to present their medicines fairly and ethically. As a result, doctors can make treatment decisions in their patients’ best interests. Sprint Prospecting.

Pharmaceutical Sales 76

Pharmaceutical Sales Training Sales Pharmaceutical 76

pharmaphorum

SEPTEMBER 26, 2022

Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks.

Pharmacology 52

Pharmacology FDA Marketing Pharma 52

European Pharmaceutical Review

JULY 18, 2024

1 As they can be highly targeted in their action, they could become the treatment of choice for clinicians and patients due to the reduced risk of side effects. This class also seem to be better tolerated across patients. Ultimately, this means that we do not yet know how to translate the potential of an ADC into a real patient impact.

Food and Drug Administration 59

Food and Drug Administration Engineering Pharmacology Side effects 59

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

European Pharmaceutical Review

JANUARY 13, 2025

Chiesi began with a 350 million investment to deliver carbon-minimal inhalers for asthma and chronic obstructive pulmonary disease (COPD) patients. In the future, a medicines value cannot be determined solely by its impact on human health, but also its impact on planetary health.

Medicine 52

Medicine Pharmaceutical Government Manufacturing 52

European Pharmaceutical Review

JULY 25, 2024

This progress underscores the potential of gene therapy to revolutionise medicine by addressing the root causes of genetic disorders. With some of the gene therapies now available, we are observing disease remission and increased life expectancy, offering patients and their families the hope they have long sought since diagnosis.

Pharmacology 52

Pharmacology Manufacturing Medicine Training 52

Pharmaceutical Technology

MAY 24, 2023

Several tetrapeptides are pharmacologically active, showing affinity and specificity for multiple receptors in protein-protein signalling. Amgen develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

Pharmaceutical Technology

MAY 15, 2023

Pyridine derivatives contain one nitrogen atom in a six-membered aromatic ring and are the most extensively used heterocycles in the field of drug design, due to their promising effect on pharmacological activity, which has led to the discovery of numerous broad-spectrum therapeutic agents.

Pharmaceutical 52

Pharmaceutical Leads Pharmacology Medicine 52

European Pharmaceutical Review

FEBRUARY 13, 2025

Oligonucleotide therapeutics (oligos), a promising class of drugs that can modulate gene expression or protein function, are reshaping modern medicine. 2 Furthermore, native oligos may form partial complementary pairs with non-target transcripts, causing off-target toxicity in patients.

Safety 52

Safety Medicine Pharmacology Leads 52

Pharmaceutical Representative Training

JUNE 22, 2024

They must be familiar with the different national authorities; the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regulations that govern the pharmaceutical marketing and sales. Ethical conduct helps maintain the company’s integrity and foster trust with HCPs and patients.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

Pharmaceutical Technology

FEBRUARY 13, 2023

As well as presenting an acceptable PK profile and demonstrating in-vivo efficacy, it becomes important to show that the candidate drug has a good safety pharmacology margin with an acceptable drug-drug interaction (DDI) profile.

Food and Drug Administration 52

Food and Drug Administration Leads Pharmaceutical Pharmaceutical research 52

Contrarian Sales Techniques

DECEMBER 5, 2023

Another game-changer has been the shift towards personalized medicine. As treatments become more tailored to individual patients, sales reps must understand complex scientific concepts and communicate them effectively. You need to comprehend and convey how these products can truly make a difference in patients' lives.

Pharmaceutical Sales 52

Pharmaceutical Sales Training Sales Pharmaceutical 52

Quantified

JUNE 28, 2022

On the one hand, patient need for access and business need to restore and accelerate sales and prescription momentum have never been more critical. Having a flawless technical grasp of the medicine is no longer sufficient. On the other hand, HCP access for the field force has never been more challenging.

Sales 52

Sales Pharma Training Management 52

European Pharmaceutical Review

MAY 2, 2023

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer.

Patients 105

Patients Medicine Marketing Medical 105

European Pharmaceutical Review

JULY 13, 2023

1,2 Moreover, except for countries such as Czechia, Denmark and Germany, the cost of these medications is borne by the patient, rather than national insurance or healthcare systems. This will lead to a higher proportion of these medicines becoming licensed, benefitting a larger number of patients. 2023 Mar 4;16(3):257-66.

Medical 98

Medical Food and Drug Administration Pharmacology Medicine 98

European Pharmaceutical Review

JANUARY 31, 2025

Over 100 biosimilar medicines are approved for nearly 30 reference medicines, testimony to the rigour of the scientific standards leading to the European authorisation process. More importantly, patient outcomes have also been transformative, with more patients getting faster access to biological therapy.

Medicine 52

Medicine Competition Marketing Patients 52

Pharmaceutical Technology

AUGUST 8, 2022

Proteus Health’s Abilify MyCite had an ingestible sensor that could track if a patient consumed the drug. You don’t want to use this to stigmatize patients or to ‘catch them lying.’ A patient probably does not know what they’re signing, but still do it in order to access whatever treatment they need, she adds.

Food and Drug Administration 122

Food and Drug Administration FDA Patients Medicine 122

Pharmaceutical Technology

DECEMBER 16, 2022

This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology. Post-Covid return and challenges.

Pharmacology 105

Pharmacology Pharma Pharmaceutical Manufacturing 105

European Pharmaceutical Review

JULY 19, 2023

The data “are compelling, particularly the significant improvements observed in both depressive and anhedonic symptoms,” stated Dr Roger S McIntyre, FRCPC, Professor of psychiatry and pharmacology, University of Toronto and Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada.

Pharmacology 98

Pharmacology Patients Safety Medicine 98

pharmaphorum

JANUARY 23, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. It] has to be a cost at a fraction of the cost at which medicines are presented today.

Pharma 97

Pharma Food Pharmacology Patients 97

Pharmaceutical Technology

NOVEMBER 3, 2022

Cardiovascular medicines were ranked as the sixth most affected drug class by shortages, as per a 2019 European Association of Hospital Pharmacists (EAHP) survey, says the organisation’s director of finance, Nenad Miljkovi?. And patients can die when we do not have these readily available,” he says. These] are life-saving medications.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111